Jiangsu Bioperfectus Technologies Stock Revenue
| 688399 Stock | 76.00 5.49 6.74% |
Jiangsu Bioperfectus Technologies fundamentals help investors to digest information that contributes to Jiangsu Bioperfectus' financial success or failures. It also enables traders to predict the movement of Jiangsu Stock. The fundamental analysis module provides a way to measure Jiangsu Bioperfectus' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Jiangsu Bioperfectus stock.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 403.2 M | 383 M |
Jiangsu | Revenue |
Jiangsu Bioperfectus Technologies Company Revenue Analysis
Jiangsu Bioperfectus' Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Jiangsu Bioperfectus Revenue | 403.18 M |
Most of Jiangsu Bioperfectus' fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Jiangsu Bioperfectus Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Jiangsu Total Revenue
Total Revenue |
|
Based on the latest financial disclosure, Jiangsu Bioperfectus Technologies reported 403.18 M of revenue. This is 94.71% lower than that of the Biotechnology sector and 45.73% lower than that of the Health Care industry. The revenue for all China stocks is 95.73% higher than that of the company.
Jiangsu Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Jiangsu Bioperfectus' direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Jiangsu Bioperfectus could also be used in its relative valuation, which is a method of valuing Jiangsu Bioperfectus by comparing valuation metrics of similar companies.Jiangsu Bioperfectus is currently under evaluation in revenue category among its peers.
Jiangsu Fundamentals
| Return On Equity | -0.0496 | ||||
| Return On Asset | -0.0315 | ||||
| Profit Margin | (0.43) % | ||||
| Operating Margin | 0.32 % | ||||
| Current Valuation | 2.56 B | ||||
| Shares Outstanding | 56.67 M | ||||
| Shares Owned By Insiders | 49.47 % | ||||
| Shares Owned By Institutions | 0.60 % | ||||
| Price To Book | 1.31 X | ||||
| Price To Sales | 10.85 X | ||||
| Revenue | 403.18 M | ||||
| Gross Profit | 3.35 B | ||||
| EBITDA | (149.31 M) | ||||
| Net Income | (384.39 M) | ||||
| Total Debt | 164.76 M | ||||
| Book Value Per Share | 57.97 X | ||||
| Cash Flow From Operations | (113.14 M) | ||||
| Earnings Per Share | (2.92) X | ||||
| Number Of Employees | 684 | ||||
| Beta | 0.96 | ||||
| Market Capitalization | 4.28 B | ||||
| Total Asset | 3.91 B | ||||
| Retained Earnings | 2.51 B | ||||
| Working Capital | 2.35 B | ||||
| Net Asset | 3.91 B |
About Jiangsu Bioperfectus Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Jiangsu Bioperfectus Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Jiangsu Bioperfectus using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Jiangsu Bioperfectus Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Jiangsu Stock
Jiangsu Bioperfectus financial ratios help investors to determine whether Jiangsu Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Jiangsu with respect to the benefits of owning Jiangsu Bioperfectus security.